Feb. 2005, Journal of Neuroscience, Vol. 25 Issue 8, Pages 1904-1913Maria L. de Ceballos, PhD, Researcher and Group Leader of the Department of Neural Plasticity at the Cajal Institute, Spain, et al., wrote the following in a Feb. 2005 article titled “Prevention of Alzheimer’s Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockage of Microglial Activation,” published in the Journal of Neuroscience:
“Our results indicate that cannabinoid receptors are important in the pathology of AD [Alzheimer's Disease] and that cannabinoids succeed in preventing the neurodegenerative process occurring in the disease.”
Comments